Logo Image
|Articles|February 5, 2008

FDA approves reduced-dose pediatric asthma inhaler

The Food and Drug Administration approved Schering-Plough's Asmanex Twisthaler (mometasone furoate inhalation powder) in a 110-mcg formulation, for preventative asthma therapy for children 4 to 11 years of age....

Related Content

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more